Cell line development and synbio workflows driven by automation
25 Apr 2024
Lori Euler and Chris Saenz from Beckman Coulter Life Sciences unveil strategies to elevate efficiency in synthetic biology workflows through automation, offering practical approaches to streamline processes and optimize productivity. In the second half of this SLAS 2024 presentation, Brian Murphy and Peter Braun, also of Beckman Coulter Life Sciences, offer valuable insights into refining the cell line development processes using automated antibody analytics on the Biomek i5 Liquid Handler. Don't miss this opportunity to learn from industry leaders about the transformative impact of automation and advanced analytics on cell line development, tackling bottlenecks, and accelerating drug development timelines.
This video was filmed at SLAS2024.
About the company
Beckman Coulter Life Sciences
Since 1935, the Beckman name has been synonymous with technologies that simplify and automate lab research and complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Visit beckman.com to learn more.
